日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A rare missense variant in RCL1 segregates with depression in extended families.

RCL1基因中的一种罕见错义变异与大家族中的抑郁症共分离

Amin N, de Vrij F M S, Baghdadi M, Brouwer R W W, van Rooij J G J, Jovanova O, Uitterlinden A G, Hofman A, Janssen H L A, Darwish Murad S, Kraaij R, Stedehouder J, van den Hout M C G N, Kros J M, van IJcken W F J, Tiemeier H, Kushner S A, van Duijn C M

Relapse after treatment with peginterferon alpha-2b alone or in combination with lamivudine in HBeAg positive chronic hepatitis B

HBeAg阳性慢性乙型肝炎患者接受聚乙二醇干扰素α-2b单药治疗或联合拉米夫定治疗后复发

Flink, H J; Buster, E H C J; Merican, I; Nevens, F; Kitis, G; Cianciara, J; de Vries, R A; Hansen, B E; Schalm, S W; Janssen, H L A

Future prospectives for the management of chronic hepatitis B

慢性乙型肝炎治疗的未来展望

Leemans, W F; Janssen, H L A; de Man, R A

Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during Peg-interferon {alpha}-2b therapy

慢性乙型肝炎患者的病情加重是由宿主因素还是病毒因素引起的?与聚乙二醇干扰素α-2b治疗期间的治疗反应有何关系?

Flink, H J; Sprengers, D; Hansen, B E; van Zonneveld, M; de Man, R A; Schalm, S W; Janssen, H L A

Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase

慢性乙型肝炎抗病毒治疗后HBeAg血清转换的持久性:与治疗类型、治疗前血清乙型肝炎病毒DNA和丙氨酸氨基转移酶的关系

van Nunen, A B; Hansen, B E; Suh, D J; Löhr, H F; Chemello, L; Fontaine, H; Heathcote, J; Song, B C; Janssen, H L A; de Man, R A; Schalm, S W